In Depth 17 Feb 2025 Biotech’s legal storm: Why securities class action lawsuits are surging Find out about what’s behind the increase of securities class action lawsuits in the biotech industry and how to prevent them. February 17, 2025 - 8 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
Best in Biotech 13 Feb 2025 Seven companies using metabolomics to decode biology Discover seven companies operating in metabolomics, the field that could significantly boost precision medicine. February 13, 2025 - 9 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
News and Trends 13 Feb 2025 DeepMind AlphaFold’s alumnus raises $40m for Latent Labs, a new AI biotech startup Find out about a new AI-driven company that emerges from stealth today to create novel protein – Latent Labs. February 13, 2025 - 6 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
News and Trends 4 Feb 2025 Akribion Therapeutics emerges from stealth with programmable cell depletion RNA technology Akribion Therapeutics emerges from stealth with €8 million in seed funding to develop a novel cancer RNA-guided approach February 4, 2025 - 6 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
News and Trends 28 Jan 2025 ITM-11 succeeds in phase 3: The first big win for radiopharma? Discover ITM and its cancer candidate ITM-11, as it brings one of the first big wins the radiopharmaceutical sector awaits. January 28, 2025 - 9 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
Best in Biotech 27 Jan 2025 Top 19 most-performing biotech stocks of 2024 Discover the top-performing biotech stocks in 2024 – from oncology to psychedelics some companies showed remarkable results. January 27, 2025 - 8 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
In Depth 24 Jan 2025 Why are there only 20 cell and gene therapies in Europe? There are 20 cell and gene therapies on Europe’s market versus 43 in the U.S. Find out more about this ecosystem. January 24, 2025 - 9 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
Best in Biotech 22 Jan 2025 Curing ALS? Sixteen companies developing new treatments in 2025 Delve into the increasingly dynamic landscape of ALS treatment development with thirteen companies advancing candidates in 2025. January 22, 2025 - 18 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
Best in Biotech 16 Jan 2025 Ten first-in-class drugs on track for FDA approval in 2025 As the year unfolds the biotech industry will look closely at these ten first-in-class drugs on track to reach FDA approval in 2025. January 16, 2025 - 13 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
In Depth 15 Jan 2025 CRISPR: The gene editing tool changing the world (2025 update) CRISPR-Cas9 has changed the world with the promise of making gene editing much easier and faster than before. But what is its real potential? January 15, 2025 - 9 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
News and Trends 9 Jan 2025 Von Willebrand disease: Star Therapeutics, Chugai and Band Therapeutics are breaking new ground Explore advances in von Willebrand disease treatment, including Star Therapeutics’ VGA039, and other key players in the space. January 9, 2025 - 7 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
Expert Advice 6 Jan 2025 What to look for in a biotech incubator Building a biotech startup can be a daunting task and often founders rely on incubators – but how to choose the right one? January 6, 2025 - 10 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email